MedPath

Comparison between stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Meta-analysis and systematic review.

Not Applicable
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000041927
Lead Sponsor
Ofuna Chuo Hospital
Brief Summary

Three BCLC factor matched studies were identified. Stereotactic body radiotherapy led to comparable OS and significantly better LC. We also identified three additional BCLC factor unmatched studies. However, considerable heterogeneity was observed for HR of OS between BCLC factor matched and unmatched studies.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
2107
Inclusion Criteria

Not provided

Exclusion Criteria

NA

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath